Lantern Pharma Valuation

LTRN Stock  USD 9.65  0.13  1.33%   
At this time, the firm appears to be overvalued. Lantern Pharma secures a last-minute Real Value of $6.94 per share. The latest price of the firm is $9.65. Our model forecasts the value of Lantern Pharma from analyzing the firm fundamentals such as Current Valuation of 65.49 M, shares owned by insiders of 15.06 %, and Return On Equity of -0.33 as well as examining its technical indicators and probability of bankruptcy. In general, most investors recommend obtaining undervalued stocks and abandoning overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
9.65
Please note that Lantern Pharma's price fluctuation is risky at this time. Calculation of the real value of Lantern Pharma is based on 3 months time horizon. Increasing Lantern Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Lantern Pharma is useful when determining the fair value of the Lantern stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Lantern Pharma. Since Lantern Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Lantern Stock. However, Lantern Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  9.65 Real  6.94 Hype  9.0 Naive  9.58
The real value of Lantern Stock, also known as its intrinsic value, is the underlying worth of Lantern Pharma Company, which is reflected in its stock price. It is based on Lantern Pharma's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Lantern Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Lantern Pharma's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
6.94
Real Value
16.05
Upside
Estimating the potential upside or downside of Lantern Pharma helps investors to forecast how Lantern stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Lantern Pharma more accurately as focusing exclusively on Lantern Pharma's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.509.8210.14
Details
Hype
Prediction
LowEstimatedHigh
0.459.0018.11
Details
Naive
Forecast
LowNext ValueHigh
0.479.5818.69
Details

Lantern Pharma Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Lantern Pharma's current stock value. Our valuation model uses many indicators to compare Lantern Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lantern Pharma competition to find correlations between indicators driving Lantern Pharma's intrinsic value. More Info.
Lantern Pharma is rated fourth overall in price to book category among related companies. It is rated second overall in beta category among related companies totaling about  0.49  of Beta per Price To Book. The ratio of Price To Book to Beta for Lantern Pharma is roughly  2.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Lantern Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lantern Pharma's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lantern Pharma's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Lantern Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Lantern Pharma and how it compares across the competition.

About Lantern Pharma Valuation

The stock valuation mechanism determines the current worth of Lantern Pharma on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Lantern Pharma. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Lantern Pharma based exclusively on its fundamental and basic technical indicators. By analyzing Lantern Pharma's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Lantern Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lantern Pharma. We calculate exposure to Lantern Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lantern Pharma's related companies.
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. The company was incorporated in 2013 and is headquartered in Dallas, Texas. Lantern Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.

8 Steps to conduct Lantern Pharma's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Lantern Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Lantern Pharma's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Lantern Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Lantern Pharma's revenue streams: Identify Lantern Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Lantern Pharma's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Lantern Pharma's growth potential: Evaluate Lantern Pharma's management, business model, and growth potential.
  • Determine Lantern Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Lantern Pharma's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Lantern Pharma Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Lantern Pharma does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding10.8 M
When determining whether Lantern Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lantern Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lantern Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lantern Pharma Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Lantern Stock analysis

When running Lantern Pharma's price analysis, check to measure Lantern Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lantern Pharma is operating at the current time. Most of Lantern Pharma's value examination focuses on studying past and present price action to predict the probability of Lantern Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lantern Pharma's price. Additionally, you may evaluate how the addition of Lantern Pharma to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Lantern Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantern Pharma. If investors know Lantern will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantern Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lantern Pharma is measured differently than its book value, which is the value of Lantern that is recorded on the company's balance sheet. Investors also form their own opinion of Lantern Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lantern Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantern Pharma's market value can be influenced by many factors that don't directly affect Lantern Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantern Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantern Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantern Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.